DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 18 filers reported holding DIREXION SHS ETF TR in Q1 2018. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,522,000 | +46.7% | 58,600 | +58.8% | 0.04% | +76.0% |
Q4 2017 | $1,719,000 | -66.3% | 36,900 | -67.1% | 0.02% | -56.9% |
Q3 2017 | $5,108,000 | +28.8% | 112,300 | +18.1% | 0.06% | -3.3% |
Q2 2017 | $3,966,000 | +375.5% | 95,100 | +293.0% | 0.06% | +361.5% |
Q1 2017 | $834,000 | – | 24,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HRT FINANCIAL LP | 50,278 | $3,704,000 | 0.16% |
Traynor Capital Management, Inc. | 6,022 | $443,000 | 0.12% |
Virtu Financial LLC | 7,445 | $549,000 | 0.05% |
Capital Analysts, LLC | 6,000 | $442,000 | 0.04% |
Tower Research Capital LLC (TRC) | 5,764 | $425,000 | 0.04% |
Ellis Investment Partners, LLC | 1,163 | $86,000 | 0.03% |
Cutler Group LLC / CA | 3,199 | $235,000 | 0.01% |
BANQUE PICTET & CIE SA | 10,120 | $746,000 | 0.01% |
Valeo Financial Advisors, LLC | 905 | $67,000 | 0.01% |
Citadel Advisors | 120,078 | $8,847,000 | 0.00% |